For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.

REXULTI® (brexpiprazole) agitation that may happen with dementia

Brexpiprazole For Alzheimer's Agitation - Is The Juice Worth The

Schizophrenia drug promising for Alzheimer's agitation - Seasons

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for

REXULTI® (brexpiprazole) Agitation associated with dementia due

Lundbeck, Otsuka drug cut agitation in Alzheimer's patients

REXULTI® (brexpiprazole), MDD

This Antipsychotic Drug Can Now Be Used to Treat Agitation in

Pharma News for Sarepta, Astellas, SiSaf, ImmPACT Bio, Otsuka

Otsuka and Lundbeck Announce U.S. Food and Drug Administration

FDA approves first drug meant to ease Alzheimer's-linked agitation